• CAS Science Spotlight Home
• Most Cited Patent Families 2001-Chemistry and Related
• About
• What's New

Home   •   Spotlight  •  pcite01  •  Most Cited Patent Families 2001-Chemistry and Related (6)

Most Cited Patent Families 2001-Chemistry and Related

Following is a CAS database record representing a highly cited patent family.

---

CAS indexed 327 chemical substances from this document. CAS subject entries for this document include: Receptors; Antidiabetic agents; Hypolipemic agents; and 1 additional concept.

CAPLUS COPYRIGHT 2002 ACS

TITLE:	Preparation of tricyclic compounds as .beta.3 adrenaline receptor agonists
INVENTOR(S):	Miyoshi, Shiro; Ogawa, Kohei
PATENT ASSIGNEE(S):	Asahi Kasei Kogyo Kabushiki Kaisha, Japan; Miyoshi, Shiro; Ogawa, Kohei
SOURCE:	PCT Int. Appl., 221 pp. CODEN: PIXXD2
LANGUAGE:	Japanese

PATENT INFORMATION:

PATENT NO.       KIND  DATE           APPLICATION NO.  DATE
---------------  ----  --------       ---------------  --------
WO 9725311        A1   19970717       WO 1996-JP3689   19961218
	 W:  AL, AM, AT, AU, AZ, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE,
	     ES, FI, GB, GE, HU, IS, KE, KG, KR, KZ, LK, LR, LS, LT, LU, LV,
	     MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI,
	     SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN, AM, AZ, BY, KG, KZ, MD,
	     RU, TJ, TM
	 RW: KE, LS, MW, SD, SZ, UG, AT, BE, CH, DE, DK, ES, FI, FR, GB, GR,
	     IE, IT, LU, MC, NL, PT, SE, BF, BJ, CF, CG, CI, CM, GA, GN, ML,
	     MR, NE, SN, TD, TG
JP 09249623       A2   19970922       JP 1996-333263   19961213
JP 3124242        B2   20010115
JP 2000239255     A2   20000905       JP 2000-45460    19961213
CA 2242351        AA   19970717       CA 1996-2242351  19961218
AU 9711708        A1   19970801       AU 1997-11708    19961218
AU 715233         B2   20000120
EP 882707         A1   19981209       EP 1996-942564   19961218
    R:  AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE, MC, PT,
	IE, FI
CN 1209119        A    19990224       CN 1996-180079   19961218
CN 1083831        B    20020501
NO 9803197        A    19980910       NO 1998-3197     19980710
US 6037362        A    20000314       US 1998-101232   19980805
US 6187809        B1   20010213       US 1999-472937   19991228
CN 1295064        A    20010516       CN 2000-131988   20001102
NO 2001002876     A    19980910       NO 2001-2876     20010611

 

ABSTRACT:
The title compds. I [R represents hydrogen or methyl; R1 represents hydrogen, halogeno, hydroxy, benzyloxy, amino, or hydroxymethyl; R2 represents hydrogen, hydroxymethyl, etc.; R6 represents hydrogen or lower alkyl; and X represents nitrogen, oxygen, sulfur, or methylene, provided that when X represents nitrogen, oxygen, or sulfur, then R9 represents hydrogen, one of R7 and R8 represents hydrogen, and the other represents hydrogen, amino, acetylamino, or hydroxy, and when X represents methylene, then R7 and R8 each represents hydrogen and R9 represents hydrogen, amino, etc.] are prepd. I are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc. (.+-.)-N-[5-[2-[2-(9H-Carbazol-2-yloxy)ethylamino]-1-hydroxyethyl]-2-hydroxy phenyl]methanesulfonamide hydrochloride at 10 mg/kg i.p. in mice increased the concn. of free fatty acids in serum.

 View full-text pdf document from MicroPatent, a participating ChemPort patent provider.